☰

Sarat C Vatsavayai - Publications

Affiliations: 
The Open University, Kents Hill, England, United Kingdom 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Vatsavayai SC, Nana AL, Yokoyama JS, Seeley WW. C9orf72-FTD/ALS pathogenesis: evidence from human neuropathological studies. Acta Neuropathologica. PMID 30368547 DOI: 10.1007/S00401-018-1921-0  0.356
2017 Celona B, von Dollen J, Vatsavayai SC, Kashima R, Johnson JR, Tang AA, Hata A, Miller BL, Huang EJ, Krogan NJ, Seeley WW, Black BL. Suppression of C9orf72 RNA repeat-induced neurotoxicity by the ALS-associated RNA-binding protein Zfp106. Elife. 6. PMID 28072389 DOI: 10.7554/Elife.19032  0.34
2016 Vatsavayai SC, Yoon SJ, Gardner RC, Gendron TF, Vargas JN, Trujillo A, Pribadi M, Phillips JJ, Gaus SE, Hixson JD, Garcia PA, Rabinovici GD, Coppola G, Geschwind DH, Petrucelli L, et al. Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia. Brain : a Journal of Neurology. PMID 27797809 DOI: 10.1093/Brain/Aww250  0.364
2015 Dallérac GM, Levasseur G, Vatsavayai SC, Milnerwood AJ, Cummings DM, Kraev I, Huetz C, Evans KA, Walters SW, Rezaie P, Cho Y, Hirst MC, Murphy KP. Dysfunctional Dopaminergic Neurones in Mouse Models of Huntington's Disease: A Role for SK3 Channels. Neuro-Degenerative Diseases. 15: 93-108. PMID 25871323 DOI: 10.1159/000375126  0.73
2012 Murphy K, Dallerac G, Milnerwood A, Cummings D, Vatsavayai S, Stramek A, Evans K, Walters S, Hirst M. B24 Dysfunctional dopaminergic neurones and biphasic activity-dependent dopamine release in mouse models of Huntington's disease Journal of Neurology, Neurosurgery, and Psychiatry. 83. DOI: 10.1136/Jnnp-2012-303524.40  0.741
2012 Hirst M, Vatsavayai S, Dallerac G, Milnerwood A, Cummings D, Rezaie P, Evans K, Stramek A, Walters S, Murphy K. B05 CAG profiling in R6/1 89Q indicates early and progressive expansion in critical neuronal populations and expansion and changes in surrounding glial cell populations Journal of Neurology, Neurosurgery & Psychiatry. 83: A7.1-A7. DOI: 10.1136/Jnnp-2012-303524.21  0.727
2011 Dallérac GM, Vatsavayai SC, Cummings DM, Milnerwood AJ, Peddie CJ, Evans KA, Walters SW, Rezaie P, Hirst MC, Murphy KP. Impaired long-term potentiation in the prefrontal cortex of Huntington's disease mouse models: rescue by D1 dopamine receptor activation. Neuro-Degenerative Diseases. 8: 230-9. PMID 21282937 DOI: 10.1159/000322540  0.78
2007 Cummings DM, Milnerwood AJ, Dallérac GM, Vatsavayai SC, Hirst MC, Murphy KP. Abnormal cortical synaptic plasticity in a mouse model of Huntington's disease. Brain Research Bulletin. 72: 103-7. PMID 17352933 DOI: 10.1016/J.Brainresbull.2006.10.016  0.793
2007 Vatsavayai SC, Dallérac GM, Milnerwood AJ, Cummings DM, Rezaie P, Murphy KP, Hirst MC. Progressive CAG expansion in the brain of a novel R6/1-89Q mouse model of Huntington's disease with delayed phenotypic onset. Brain Research Bulletin. 72: 98-102. PMID 17352932 DOI: 10.1016/J.Brainresbull.2006.10.015  0.75
2006 Cummings DM, Milnerwood AJ, Dallérac GM, Waights V, Brown JY, Vatsavayai SC, Hirst MC, Murphy KP. Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease. Human Molecular Genetics. 15: 2856-68. PMID 16905556 DOI: 10.1093/Hmg/Ddl224  0.783
2006 Milnerwood AJ, Cummings DM, Dallérac GM, Brown JY, Vatsavayai SC, Hirst MC, Rezaie P, Murphy KP. Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease. Human Molecular Genetics. 15: 1690-703. PMID 16600988 DOI: 10.1093/Hmg/Ddl092  0.784
Show low-probability matches.